公司简介

Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.

主要成员

Ted Slocomb、David Nagler、John Gray、Thomas Schuetz、Mary Newman

产品/服务

• 科技服务
• DTC基因检测

gene therapy

Audentes。

AT132 - X-Linked Myotubular Myopathy

AT342-Crigler-Najjar Syndrome

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2013-07	OrbiMed	$30M
Series B	2014-12	Deerfield	$42.5M
Series C	2015-10	Sofinnova Ventures，Redmile Group	$65M

关联公司